Archived

The document provides a detailed account of federal rules, regulations, and executive orders that were either revoked, paused, or placed under review following the January 20, 2021, Regulatory Freeze Pending Review Presidential Memorandum, issued at the start of the Biden administration. Major actions included the revocation of prior executive orders such as EO 13950, which addressed race and sex

The document provides a detailed overview of federal efforts to address regulatory burden and reform policies related to federally funded research, based on statutory requirements from acts such as the 21st Century Cures Act and the American Innovation and Competitiveness Act (AICA). Key reform areas include the establishment of a Research Policy Board, interagency working groups, harmonization of

The Common Rule Summary Table outlines significant revisions to federal regulations governing human subjects research. The final rule, effective from January 19, 2018 (with special provisions for cooperative research effective January 20, 2020), distinguishes between non-identified and identifiable biospecimens, treating identifiable biospecimens and private information equivalently and providing

The document, produced by the Council on Governmental Relations (COGR), provides a comprehensive overview of federal regulatory changes affecting the conduct and management of research under federal grants and contracts since the 1991 imposition of a 26% cap on administrative costs in Facilities and Administrative (F&A) cost recovery. Organized chronologically, it lists significant regulations

Document

The document outlines the current focus areas and activities of the Council on Governmental Relations (COGR) as of August 17, 2015, categorized under four main committees: Contracts and Intellectual Property, Costing Policies, Research Compliance and Administration, and Research and Regulatory Reform. The Contracts and Intellectual Property Committee addresses issues related to compliance with the